Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiamma Buttitta

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Pathology|August 5, 2003
Survivin gene expression in early-stage non-small cell lung cancerMonica Falleni, Caterina Pellegrini, Antonio Marchetti, et al.
Cancer Research|May 1, 2002
Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patientsAntonio Marchetti, Nicola Tinari, Fiamma Buttitta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2011
Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutationsAntonio Marchetti, Lara Felicioni, Sara Malatesta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomasMattia Barbareschi, Fiamma Buttitta, Lara Felicioni, et al.
The Journal of Clinical Investigation|October 20, 2007
Survival prediction of stage I lung adenocarcinomas by expression of 10 genesFabrizio Bianchi, Paolo Nuciforo, Manuela Vecchi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 27, 2016
ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing AlgorithmAntonio Marchetti, Alessia Di Lorito, Maria Vittoria Pace, et al.
The Journal of Pathology|December 15, 2005
PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinomaFiamma Buttitta, Lara Felicioni, Fabio Barassi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinomaFiamma Buttitta, Caterina Pellegrini, Antonio Marchetti, et al.
Pathologica|February 15, 2023
Full cost of diagnostic pathology for lung carcinoma in Italy: results from four Pathology UnitsCarlo Lazzaro, Giovanni Fattore, Massimo Barberis, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2014
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic controlDonato Santovito, Velia De Nardis, Pamela Marcantonio, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Pathology|August 5, 2003
Survivin gene expression in early-stage non-small cell lung cancerMonica Falleni, Caterina Pellegrini, Antonio Marchetti, et al.
Cancer Research|May 1, 2002
Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patientsAntonio Marchetti, Nicola Tinari, Fiamma Buttitta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2011
Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutationsAntonio Marchetti, Lara Felicioni, Sara Malatesta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomasMattia Barbareschi, Fiamma Buttitta, Lara Felicioni, et al.
The Journal of Clinical Investigation|October 20, 2007
Survival prediction of stage I lung adenocarcinomas by expression of 10 genesFabrizio Bianchi, Paolo Nuciforo, Manuela Vecchi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 27, 2016
ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing AlgorithmAntonio Marchetti, Alessia Di Lorito, Maria Vittoria Pace, et al.
The Journal of Pathology|December 15, 2005
PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinomaFiamma Buttitta, Lara Felicioni, Fabio Barassi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinomaFiamma Buttitta, Caterina Pellegrini, Antonio Marchetti, et al.
Pathologica|February 15, 2023
Full cost of diagnostic pathology for lung carcinoma in Italy: results from four Pathology UnitsCarlo Lazzaro, Giovanni Fattore, Massimo Barberis, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2014
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic controlDonato Santovito, Velia De Nardis, Pamela Marcantonio, et al.
Pageof 6